Counterpoint: The evidence does not support universal screening and treatment in children

Journal of Clinical Lipidology

Volumn 9, Issue 5, 2015, Pages S101-S106

  Belamarich, Peter F ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiovascular risk; Children; Controversy; Guidelines; Lipid screening; Overdiagnosis; Statin

Indexed keywords

ATORVASTATIN; CHOLESTEROL ESTER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NON HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; UNCLASSIFIED DRUG;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; CHILD CARE; CORONARY ARTERY ATHEROSCLEROSIS; DIET; DRUG SAFETY; FAMILIAL HYPERCHOLESTEROLEMIA; HUMAN; LIPID ANALYSIS; LOW CHOLESTEROL DIET; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHABDOMYOLYSIS; SCREENING TEST; CARDIOVASCULAR DISEASES; HEALTH CARE PLANNING; MASS SCREENING; PEDIATRICS;

CARDIOVASCULAR DISEASES; CHILD; HEALTH PLAN IMPLEMENTATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MASS SCREENING; PEDIATRICS; PRACTICE GUIDELINES AS TOPIC;

EID: 84940951053     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2015.07.001     Document Type: Review

References (53)

1. F.H. Schilling, C. Spix, F. Berthold, and et al. Neuroblastoma screening at one year of age N Engl J Med 346 14 2002 1047 1053
2. K. Yamamoto, R. Hanada, A. Kikuchi, and et al. Spontaneous regression of localized neuroblastoma detected by mass screening J Clin Oncol 16 4 1998 1265 1269
3. M. LeFevre, and V. Moyer PSA screening: good evidence shows little benefit, significant harms Oncology (Williston Park) 27 10 2013 981 982
4. H.S. Ahn, H.J. Kim, and H.G. Welch Korea's thyroid-cancer "epidemic"-screening and overdiagnosis N Engl J Med 371 19 2014 1765 1767
5. J.E. Rossouw, G.L. Anderson, R.L. Prentice, and et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial JAMA 288 3 2002 321 333
6. N.J. Stone, J.G. Robinson, A.H. Lichtenstein, and et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 63 25 Pt B 2014 2889 2934
7. H.C. Gooding, A.M. Rodday, J.B. Wong, and et al. Application of pediatric and adult guidelines for treatment of lipid levels among US adolescents transitioning to young adulthood JAMA Pediatr 169 2015 569 574
8. R.F. Redberg Less is more Arch Intern Med 170 7 2010 584
9. A.R. Schroeder, S.J. Harris, and T.B. Newman Safely doing less: a missing component of the patient safety dialogue Pediatrics 128 6 2011 e1596 e1597
10. Force USPST Screening for lipid disorders in children: US Preventive Services Task Force recommendation statement Pediatrics 120 1 2007 e215 e219
11. L.A. Friedman, J.A. Morrison, S.R. Daniels, W.F. McCarthy, and D.L. Sprecher Sensitivity and specificity of pediatric lipid determinations for adult lipid status: findings from the Princeton Lipid Research Clinics Prevalence Program Follow-up Study Pediatrics 118 1 2006 165 172
12. Expert Panel on Integrated Guidelines for Cardiovascular H, Risk Reduction in C, Adolescents, National Heart L, Blood I Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report Pediatrics 128 Suppl 5 2011 S213 S256
13. N. Rifai, E. Neufeld, P. Ahlstrom, E. Rimm, L. D'Angelo, and J.M. Hicks Failure of current guidelines for cholesterol screening in urban African-American adolescents Pediatrics 98 3 Pt 1 1996 383 388
14. A.R. Schroeder, and R.F. Redberg Cholesterol screening and management in children and young adults should start early-NO! Clin Cardiol 35 11 2012 665 668
15. M.W. Gillman, and S.R. Daniels Is universal pediatric lipid screening justified? JAMA 307 3 2012 259 260
16. K. Bibbins-Domingo, P. Coxson, M.J. Pletcher, J. Lightwood, and L. Goldman Adolescent overweight and future adult coronary heart disease N Engl J Med 357 23 2007 2371 2379
17. P. Poirier, B.W. McCrindle, and L.A. Leiter Obesity-it must not remain the neglected risk factor in cardiology Can J Cardiol 31 2 2015 105 108
18. N. Doshi, E.M. Perrin, S. Lazorick, D. Esserman, and M.J. Steiner Short-term change in body mass index in overweight adolescents following cholesterol screening Arch Pediatr Adolesc Med 163 9 2009 812 817
19. R.V. Luepker, C.L. Perry, S.M. McKinlay, and et al. Outcomes of a field trial to improve children's dietary patterns and physical activity. The Child and Adolescent Trial for Cardiovascular Health. CATCH collaborative group JAMA 275 10 1996 768 776
20. P.R. Nader, M. Yang, R.V. Luepker, and et al. Parent and physician response to children's cholesterol values of 200 mg/dL or greater: the Child and Adolescent Trial for Cardiovascular Health Experiment Pediatrics 99 5 1997 E5
21. C.M. Lannon, and J. Earp Parents' behavior and attitudes toward screening children for high serum cholesterol levels Pediatrics 89 6 Pt 2 1992 1159 1163
22. Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol. The Dietary Intervention Study in Children (DISC). The Writing Group for the DISC Collaborative Research Group JAMA 273 18 1995 1429 1435
23. D.R. Jacobs Jr., and E. Barrett-Connor Retest reliability of plasma cholesterol and triglyceride. The Lipid Research Clinics Prevalence Study Am J Epidemiol 116 6 1982 878 885
24. G. Schectman, M. Patsches, and E.A. Sasse Variability in cholesterol measurements: comparison of calculated and direct LDL cholesterol determinations Clin Chem 42 5 1996 732 737
25. M. Law, and A.R. Rudnicka Statin safety: a systematic review Am J Cardiol 97 8A 2006 52C 60C
26. M. Law, and N.J. Wald Efficacy and safety of cholesterol-lowering treatment Lancet 367 9509 2006 469 470 author reply 70-1
27. E.J. Mills, P. Wu, G. Chong, and et al. Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials QJM 104 2 2011 109 124
28. B.M. Psaty, and F.P. Rivara Universal screening and drug treatment of dyslipidemia in children and adolescents JAMA 307 3 2012 257 258
29. S.N. Rajpathak, D.J. Kumbhani, J. Crandall, N. Barzilai, M. Alderman, and P.M. Ridker Statin therapy and risk of developing type 2 diabetes: a meta-analysis Diabetes Care 32 10 2009 1924 1929
30. FDA Drug Safety Communication: important safety label changes to cholesterol-lowering statin drugs. 2012. Available at: http://www.fda.gov/Drugs/DrugSafety/ucm293101.htm#sa. Accessed May 19, 2015.
31. J. Yeboah, S. Sillau, J.C. Delaney, and et al. Implications of the new American College of Cardiology/American Heart Association cholesterol guidelines for primary atherosclerotic cardiovascular disease event prevention in a multi ethnic cohort: Multi-Ethnic Study of Atherosclerosis (MESA) Am Heart J 169 3 2015 387 395.e3
32. H.J. Avis, M.N. Vissers, E.A. Stein, and et al. A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia Arterioscler Thromb Vasc Biol 27 8 2007 1803 1810
33. A. Vuorio, J. Kuoppala, P.T. Kovanen, and et al. Statins for children with familial hypercholesterolemia Cochrane database Syst Rev 7 2014 CD006401
34. H.J. Avis, B.A. Hutten, C. Gagne, and et al. Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia J Am Coll Cardiol 55 11 2010 1121 1126
35. L.E. Schanberg, C. Sandborg, H.X. Barnhart, and et al. Use of atorvastatin in systemic lupus erythematosus in children and adolescents Arthritis Rheum 64 1 2012 285 296
36. D.M. Kusters, H.J. Avis, E. de Groot, and et al. Ten-year follow-up after initiation of statin therapy in children with familial hypercholesterolemia JAMA 312 10 2014 1055 1057
37. B. Belay, P.F. Belamarich, and C. Tom-Revzon The use of statins in pediatrics: knowledge base, limitations, and future directions Pediatrics 119 2 2007 370 380
38. T.B. Newman, M.J. Pletcher, and S.B. Hulley Overly aggressive new guidelines for lipid screening in children: evidence of a broken process Pediatrics 130 2 2012 349 352
39. B.A. Hamelin, and J. Turgeon Hydrophilicity/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors Trends Pharmacol Sci 19 1 1998 26 37
40. B. Yeganeh, E. Wiechec, S.R. Ande, and et al. Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease Pharmacol Ther 143 1 2014 87 110
41. A. Yamashita, M. Morioka, H. Kishi, and et al. Statin treatment rescues FGFR3 skeletal dysplasia phenotypes Nature 513 7519 2014 507 511
42. J. Liu, L.P. Zhu, X.L. Yang, H.L. Huang, and D.Q. Ye HMG-CoA reductase inhibitors (statins) and bone mineral density: a meta-analysis Bone 54 1 2013 151 156
43. A.B. Csoka, and M. Szyf Epigenetic side-effects of common pharmaceuticals: a potential new field in medicine and pharmacology Med Hypotheses 73 5 2009 770 780
44. S.R. Vinci, S.L. Rifas-Shiman, J.K. Cheng, R.C. Mannix, M.W. Gillman, and S.D. de Ferranti Cholesterol testing among children and adolescents during health visits JAMA 311 17 2014 1804 1807
45. D.B. Dixon, A.P. Kornblum, L.M. Steffen, X. Zhou, and J. Steinberger Implementation of lipid screening guidelines in children by primary pediatric providers J Pediatr 164 3 2014 572 576
46. P.F. Belamarich, R. Gandica, R.E. Stein, and A.D. Racine Drowning in a sea of advice: pediatricians and American Academy of Pediatrics policy statements Pediatrics 118 4 2006 e964 e978
47. C. Norlin, M.A. Crawford, C.T. Bell, X. Sheng, and M.T. Stein Delivery of well-child care: a look inside the door Acad Pediatr 11 1 2011 18 26
48. D.C. Grossman, V.A. Moyer, B.M. Melnyk, R. Chou, T.G. DeWitt Force USPST The anatomy of a US Preventive Services Task Force Recommendation: lipid screening for children and adolescents Arch Pediatr Adolesc Med 165 3 2011 205 210
49. E.S. Ford, C. Li, G. Zhao, and A.H. Mokdad Concentrations of low-density lipoprotein cholesterol and total cholesterol among children and adolescents in the United States Circulation 119 8 2009 1108 1115
50. D.P. Wilson, C. McNeal, and P. Blackett Pediatric dyslipidemia: recommendations for clinical management South Med J 108 1 2015 7 14
51. G.F. Watts, S. Gidding, A.S. Wierzbicki, and et al. Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation J Clin Lipidol 8 2 2014 148 172
52. N.M. Wilkinson, J. Page, A.G. Uribe, V. Espinosa, and D.A. Cabral Establishment of a pilot pediatric registry for chronic vasculitis is both essential and feasible: a Childhood Arthritis and Rheumatology Alliance (CARRA) survey J Rheumatol 34 1 2007 224 226
53. T. Beukelman, S. Ringold, T.E. Davis, and et al. Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: a cross-sectional analysis of the CARRA Registry J Rheumatol 39 9 2012 1867 1874